Europe’s Next-Generation Sequencing Market Expected to Exceed $6.40 Billion by 2030
Meticulous Research®– a leading global market
research company, published a research report titled "Europe NGS Market by Offering (Kits [Library Prep, QC, DNA
Extraction], System), Type (Genome, Exome, Targeted), Application
(Reproductive, Oncology, Infectious, CVD, Drug Discovery), Technology (SBS,
Nanopore, Nanoball, SMRT Seq, DNB) – Forecast to 2030. "
Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=5744?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_content=31-07-2024
In the ever-evolving field of genomic technologies,
Europe’s Next-Generation Sequencing (NGS) market is poised for significant
growth, projected to reach $6.40 billion by 2030, with a robust CAGR of 14.8%.
This analysis, provided by Meticulous Research®, delves into the key drivers,
challenges, and opportunities shaping the market's future.
Key Drivers
Several factors are driving the expansion of Europe’s
NGS market. The increasing prevalence of cancer and the broadening applications
of NGS in cancer treatment and research are major contributors. Additionally,
the declining costs of genome sequencing, technological advancements enhancing
sequencing processes, and rising pharmaceutical R&D expenditures are
propelling market growth. However, challenges such as the high costs associated
with NGS systems and consumables, as well as competition from alternative
technologies, persist.
Emerging Opportunities
Despite these challenges, the market offers numerous
opportunities. The growing adoption of bioinformatics and genomic data
management solutions, along with government support for large-scale genomic
sequencing projects, presents promising growth avenues. Nevertheless, obstacles
such as a shortage of skilled professionals and regulatory concerns in
diagnostic testing remain.
Key Market Players
Leading companies in Europe’s NGS market include
Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La
Roche Ltd. These firms are at the forefront of innovation, driving the
advancement of genomic technologies.
Market Segmentation and Outlook
The European NGS market is segmented by offering,
sequencing type, technology, application, end user, and geography. Among these,
consumables play a crucial role, with the targeted genome sequencing segment
leading the way. Sequencing by synthesis technology holds the largest market
share due to its accuracy and high throughput.
Geographic Insights
Germany emerges as the leading region in Europe’s NGS
market, holding the largest share. This dominance is attributed to the growing
number of sequencing projects, increasing applications in research, and
heightened awareness of NGS-based tests.
As Europe’s NGS
market continues to expand, stakeholders are well-positioned to capitalize on
the opportunities through innovation and strategic collaborations, unlocking
the full potential of this burgeoning industry.
About Meticulous
Research®:
Meticulous Research® was founded
in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a
private limited company under the Companies Act, 1956. Since its incorporation,
the company has become the leading provider of premium market intelligence in
North America, Europe, Asia-Pacific, Latin America, and the Middle East &
Africa.
The name of our company defines
our services, strengths, and values. Since the inception, we have only thrived
to research, analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research techniques, we
have built strong capabilities in data collection, interpretation, and analysis
of data including qualitative and quantitative research with the finest team of
analysts. We design our meticulously analyzed intelligent and value-driven syndicate
market research reports, custom studies, quick turnaround research, and
consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment